<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(9)</volume><submitter>Maksin IV</submitter><pubmed_abstract>Lateral flow immunoassays (LFAs) are widely recognized as a powerful and versatile analytical platform. Nevertheless, the development of multiplex formats remains a distinct challenge. The aim of this study was to develop a multiplex LFA using gold nanoparticles (GNPs) as a label, selected for their ease of synthesis and functionalization with biomolecules. We provide practical recommendations regarding protein-hapten synthesis, membrane selection, application buffer composition, and methods to improve the long-term stability of the freeze-dried gold conjugate. The developed assay shows good tolerance to high-fat milk, stability at elevated temperatures, and promising sensitivity, with visual detection limits of 4-100 ng/mL for β-lactams, 1-10 ng/mL for tetracyclines, 50 ng/mL for streptomycin, and 0.3 ng/mL for chloramphenicol.</pubmed_abstract><journal>Biosensors</journal><pagination>592</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12467014</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Development of a Multiplex Lateral Flow Immunoassay for the Detection of Antibiotics in Milk Utilizing Lyophilized Gold Nanoparticle Conjugates.</pubmed_title><pmcid>PMC12467014</pmcid><pubmed_authors>Kesareva VA</pubmed_authors><pubmed_authors>Kuandykova A</pubmed_authors><pubmed_authors>Polyakova DI</pubmed_authors><pubmed_authors>Khunteev GA</pubmed_authors><pubmed_authors>Maksin IV</pubmed_authors><pubmed_authors>Kirillova YG</pubmed_authors><pubmed_authors>Simonova EI</pubmed_authors><pubmed_authors>Ivanov VS</pubmed_authors><pubmed_authors>Luzyanin TA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Development of a Multiplex Lateral Flow Immunoassay for the Detection of Antibiotics in Milk Utilizing Lyophilized Gold Nanoparticle Conjugates.</name><description>Lateral flow immunoassays (LFAs) are widely recognized as a powerful and versatile analytical platform. Nevertheless, the development of multiplex formats remains a distinct challenge. The aim of this study was to develop a multiplex LFA using gold nanoparticles (GNPs) as a label, selected for their ease of synthesis and functionalization with biomolecules. We provide practical recommendations regarding protein-hapten synthesis, membrane selection, application buffer composition, and methods to improve the long-term stability of the freeze-dried gold conjugate. The developed assay shows good tolerance to high-fat milk, stability at elevated temperatures, and promising sensitivity, with visual detection limits of 4-100 ng/mL for β-lactams, 1-10 ng/mL for tetracyclines, 50 ng/mL for streptomycin, and 0.3 ng/mL for chloramphenicol.</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-05-01T03:19:23.499Z</modification><creation>2026-05-01T03:10:46.373Z</creation></dates><accession>S-EPMC12467014</accession><cross_references><pubmed>41002332</pubmed><doi>10.3390/bios15090592</doi></cross_references></HashMap>